Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib before nephrectomy in metastatic renal cell carcinoma
2006-006491-38Phase 2Active
- Sponsor
- Netherlands Cancer Institute
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sunitinib in renal cell carcinoma (RCC), sponsored by Netherlands Cancer Institute. Primary endpoint: Objective response in the primary tumor. Started Dec 2006; status: active.
02
Drugs
sunitinib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on 2006-006491-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006491-38.